Skip to main content
CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.390
-0.020 (-4.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.390
-0.000 (-0.03%)
After-hours: Apr 28, 2026, 6:39 PM EDT

CollPlant Biotechnologies Revenue

In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth. CollPlant Biotechnologies had revenue of $60.00K in the quarter ending December 31, 2025, a decrease of -63.41%.

Revenue (ttm)
$2.37M
Revenue Growth
+360.39%
P/S Ratio
2.37
Revenue / Employee
$60,795
Employees
39
Market Cap
5.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.37M1.86M360.39%
Dec 31, 2024515.00K-10.44M-95.30%
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Moolec Science 7.83M
XTL Biopharmaceuticals 968.00K
Bio Green Med Solution 747.00K
BioRestorative Therapies 359.70K
Cardio Diagnostics Holdings 14.83K
Alaunos Therapeutics 5.00K
Ernexa Therapeutics 1,000.00
Revenue Rankings

CLGN News

More News